Literature DB >> 23812046

Reply to Robinson.

Dimpy P Shah, Mark F Munsell, Roy F Chemaly.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23812046      PMCID: PMC3733514          DOI: 10.1093/infdis/jit257

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Ribavirin for upper respiratory tract infections.

Authors:  Joan L Robinson
Journal:  J Infect Dis       Date:  2013-06-27       Impact factor: 5.226

2.  Living with p values: resurrecting a Bayesian perspective on frequentist statistics.

Authors:  Sander Greenland; Charles Poole
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

3.  Aerosolized ribavirin for patients with cancer and respiratory syncytial virus infection.

Authors:  Gerd Fätkenheuer; Daniel Gillor; Martin Platten; Matthias Kochanek; Bernd Salzberger
Journal:  J Infect Dis       Date:  2013-02-26       Impact factor: 5.226

Review 4.  Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.

Authors:  Jharna N Shah; Roy F Chemaly
Journal:  Blood       Date:  2010-12-07       Impact factor: 22.113

5.  An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection.

Authors:  Roy F Chemaly; Harrys A Torres; Mark F Munsell; Dimpy P Shah; Dhanesh B Rathod; Gerald P Bodey; Chitra Hosing; Chadi Saifan; Issam I Raad; Richard E Champlin
Journal:  J Infect Dis       Date:  2012-08-22       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.